A detailed history of 626 Financial, LLC transactions in Pfizer Inc stock. As of the latest transaction made, 626 Financial, LLC holds 42,335 shares of PFE stock, worth $1.1 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
42,335
Previous 41,405 2.25%
Holding current value
$1.1 Million
Previous $1.16 Million 5.79%
% of portfolio
0.69%
Previous 0.68%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $25,761 - $29,192
930 Added 2.25%
42,335 $1.23 Million
Q2 2024

Jul 12, 2024

BUY
$25.26 - $29.6 $38,976 - $45,672
1,543 Added 3.87%
41,405 $1.16 Million
Q1 2024

Apr 18, 2024

BUY
$25.89 - $29.73 $66,847 - $76,762
2,582 Added 6.93%
39,862 $1.11 Million
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $108,962 - $141,529
-4,170 Reduced 10.06%
37,280 $1.07 Million
Q3 2023

Oct 11, 2023

BUY
$32.09 - $37.51 $111,191 - $129,972
3,465 Added 9.12%
41,450 $1.37 Million
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $7,910 - $9,152
219 Added 0.58%
37,985 $1.39 Million
Q1 2023

Apr 12, 2023

BUY
$39.39 - $51.28 $37,617 - $48,972
955 Added 2.59%
37,766 $1.54 Million
Q4 2022

Jan 24, 2023

BUY
$41.75 - $54.5 $303,439 - $396,106
7,268 Added 24.6%
36,811 $0
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $291,397 - $355,723
6,659 Added 29.1%
29,543 $1.29 Million
Q2 2022

Jul 12, 2022

BUY
$46.53 - $55.17 $39,178 - $46,453
842 Added 3.82%
22,884 $1.2 Million
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $53,847 - $66,724
1,177 Added 5.64%
22,042 $1.14 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $48,633 - $72,091
-1,177 Reduced 5.34%
20,865 $1.23 Million
Q1 2021

Apr 14, 2022

BUY
$33.49 - $37.77 $738,186 - $832,526
22,042 New
22,042 $1.14 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track 626 Financial, LLC Portfolio

Follow 626 Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 626 Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 626 Financial, LLC with notifications on news.